Global (United States, European Union and China) Dermatology Drug Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: World Dermatology Drug Market

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%. 

In 2019, the market size of Dermatology Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatology Drug. This report studies the global market size of Dermatology Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India, and Southeast Asia). This study presents the Dermatology Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. 
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019

Market Segmentation, Outlook & Viewpoint: World Dermatology Drug Market

Segmentation by Product Type: Breakdown of data from the year 2014 to 2019 and forecast until 2025: External Use
Oral
Injection

Segmentation by Application: Breakdown of data from the year 2014 to 2019 and forecast until 2025: 

Psoriasis
Skin Infections
Acne
Dermatitis
Other

Top Companies & Key Players: World Dermatology Drug Market
 
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline

Key Industry Development

In Aug 2020, LEO Pharma A/S announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million. The agreement represents a milestone in the roll-out of LEO Pharma’s 2030 strategy which increases the company’s focus on new innovative solutions for medical dermatology.
The divested portfolio comprises four products within bone disorders/nephrology, dermatology and gynecology: One-Alpha©(Alfacalcidol), Locoid©(Cortisol), Pimafucin©(Natamycin), and Zineryt©(Erythromycin 40 mg and Zinc Acetate dihydrate). The annual turnover of the portfolio in 2019 amounted to approximately EUR 110 million.
The transaction is expected to close by December 2020, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals. Following the closing, LEO Pharma and Cheplapharm will work closely together to ensure a smooth and effective transition of the products and business.

Key Insights Covered: World Dermatology Drug Market
1.  North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue, and growth rate) of Dermatology Drug industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate, and gross margin) of Dermatology Drug industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Dermatology Drug industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Dermatology Drug industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Dermatology Drug industry.

Research Methodology: Global Dermatology Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.